CRM: Boston Scientific's gain is St. Jude Medical's loss

The FDA's approval of Boston Scientific's Emblem S-ICD prompts Wells Fargo to downgrade St. Jude Medical, saying Boston Scientific is poised to take share in the cardiac rhythm management market.

Boston Scientific, St. Jude Medical

News Well, Cardiac Rhythm Management, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1OetMKn